title: A nicotinic acetylcholine receptor subunit from insect brain forms a non-desensitising homo-oligomeric nicotinic acetylcholine receptor when expressed in Xenopus oocytes.
abstract: The locust alpha-like nicotinic receptor subunit alpha L1 was expressed in Xenopus oocytes. Small but reproducible currents were elicited by application of high concentrations of nicotine, demonstrating that alpha L1 is capable of forming homo-oligomeric channels. Nicotine-evoked currents were blocked by alpha-bungarotoxin and methyllycaconitine. Comparison with chick alpha 7 receptors showed that the two receptors differ with respect to nicotine sensitivity and time course of evoked currents. Nicotine dose-response curves gave EC50 values of 24 and 830 microM for alpha 7 and alpha L1 respectively. Whereas alpha 7 responses showed characteristic fast onset and rapid desensitization within 3 s, alpha L1 currents displayed a slow onset and showed no tendency to desensitize during 45 s of agonist application. Thus alpha L1 is a novel nicotine subunit for the further exploration of structure-function relationships of ligand-gated ion channels. The question of the subunit composition of native insect receptors remains open.
authors.affiliation: School of Biology and Biochemistry, University of Bath, UK.
authors.forename: M
authors.initials: M
authors.lastname: Amar
authors.forename: P
authors.initials: P
authors.lastname: Thomas
authors.forename: S
authors.initials: S
authors.lastname: Wonnacott
authors.forename: G G
authors.initials: GG
authors.lastname: Lunt
mesh_terms: D000818:Animals; D001923:Brain Chemistry / Q000502:physiology*; D002038:Bungarotoxins / Q000494:pharmacology; D018076:DNA, Complementary / Q000096:biosynthesis; D006110:Grasshoppers / Q000378:metabolism*; D015640:Ion Channel Gating; D008564:Membrane Potentials / Q000187:drug effects; D009538:Nicotine / Q000008:administration & dosage / Q000494:pharmacology; D018722:Nicotinic Agonists / Q000008:administration & dosage / Q000494:pharmacology; D018733:Nicotinic Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D009865:Oocytes / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000096:biosynthesis* / Q000235:genetics; D013329:Structure-Activity Relationship; D014981:Xenopus
chemical_list: D002038:Bungarotoxins; D018076:DNA, Complementary; D018722:Nicotinic Agonists; D018733:Nicotinic Antagonists; D011978:Receptors, Nicotinic; D009538:Nicotine